Gene therapy for advanced lymphoma gets FDA approval

People with advanced lymphoma now have another type of treatment to consider. The Food and Drug Administration has approved Yescarta, a cell-based gene therapy designed to treat large B-cell lymphoma created by Kite Pharma. It’s the second time the F…

No Responses to “Gene therapy for advanced lymphoma gets FDA approval”

Post a Comment